16 votes

mRNA melanoma vaccine halves the risk of death and recurrence

Posted by DefinitelyNotAFae
Tags: medicine, united kingdom, pharmaceuticals, cancer, melanoma, mrna, nhs, mortality rates, vaccines, clinical trials, cancer research uk, uplifting, author.andrew gregory, author.natasha may, source.the guardian
https://www.theguardian.com/society/article/2024/jun/03/extremely-impressive-melanoma-jab-trial-results-excite-doctors

Link information

This data is scraped automatically and may be incorrect.

Title
'Extremely impressive': melanoma jab trial results excite doctors
Authors
Andrew Gregory, Natasha May
Published
Jun 4 2024
Word count
620 words

1 comment

  1. DefinitelyNotAFae
    (edited )
    Link
    Researchers note that five- and ten-year recurrence rates still need to be studied, but the highest risk is in the first two years. Of note is that these vaccines are custom-built for each...

    Melanoma affects more than 150,000 people a year globally, according to 2020 figures from World Cancer Research Fund International.

    Patients who received the vaccine after having a stage 3 or 4 melanoma removed had a 49% lower risk of dying or the disease recurring after three years, data presented at the world’s largest cancer conference showed. The NHS in the UK is among the organisations testing the jab.

    Researchers note that five- and ten-year recurrence rates still need to be studied, but the highest risk is in the first two years. Of note is that these vaccines are custom-built for each patient; the vaccine is not preventative but part of the treatment, and the results were alongside the existing therapy, not instead.

    However, I think this is really promising! A similar trial targeting breast cancer in Vienna is also promising!

    4 votes